InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Sjuts Dustin S, Chief Executive Officer. Director active across 1 company, notably Revance Therapeutics, Inc.. Aggregated, 22 filings have been recorded. Split: 0 buy · 1 sell. Total volume traded: €143k. Activity tracked since 30 June 2021. The latest transaction was disclosed on 15 March 2024 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Declarations22 total
2,967 shares@ US$5.3052.6% of flowCommon StockSEC:0001479290-24-000068:0
22,110 shares0Common StockSEC:0001479290-24-000054:0
264 shares@ US$7.470.3% of flowCommon StockSEC:0001479290-24-000006:0
4,712 shares@ US$8.086.2% of flowCommon StockSEC:0001479290-23-000116:0
22,620 shares0Common StockSEC:0001479290-23-000097:0
1,000 shares@ US$15.6062.6% of flowCommon StockSEC:0001479290-23-000082:0
5,000 shares@ US$30.819225.6% of flowCommon StockSEC:0001479290-23-000079:0
52,395 shares0Common StockSEC:0001479290-23-000073:0
2,967 shares@ US$30.6515.2% of flowCommon StockSEC:0001479290-23-000039:0
52,396 shares0Common StockSEC:0001479290-23-000035:0
2,766 shares@ US$33.2115.4% of flowCommon StockSEC:0001479290-23-000019:0
605 shares@ US$12.18051.2% of flowCommon StockSEC:0001479290-23-000002:0
2,916 shares@ US$21.5010.5% of flowCommon StockSEC:0001479290-22-000105:0
1,000 shares@ US$11.7472.0% of flowCommon StockSEC:0001479290-22-000073:0
1,835 shares@ US$15.7926.0% of flowCommon StockSEC:0001209191-22-019707:0
2,134 shares@ US$13.3524.7% of flowCommon StockSEC:0001479290-22-000025:0
513 shares@ US$15.921.3% of flowCommon StockSEC:0001479290-21-000175
513 shares@ US$15.927.1% of flowCommon StockSEC:0001479290-21-000175:0
35,920 shares0Common StockSEC:0001479290-21-000167:0
35,920 shares0Common StockSEC:0001479290-21-000167
882 shares@ US$24.08917.6% of flowCommon StockSEC:0001479290-21-000134:0
882 shares@ US$24.0893.2% of flowCommon StockSEC:0001479290-21-000134
22 of 22 declarations
About Sjuts Dustin S
Dustin S. Sjuts is the CEO and President of Revance Therapeutics, Inc. In this role, he is responsible for the overall management of the company and the implementation of its strategy. Revance Therapeutics, Inc. is an innovative biopharmaceutical company. Dustin leverages his expertise to lead the company towards sustainable growth and strengthen its market position.
